MedTrace Logo

Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.

NCT07148609 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia.

The main questions it aims to answer are:

* Does video game-facilitated group activity enhance the quality of life as measured by a standardized scale (WHOQOL) in patients with schizophrenia hospitalized in a psychiatric hospital?
* Can video game-facilitated group activity promote social function as measured by a specific scale (PSP) in patients with schizophrenia hospitalized in a psychiatric hospital?

Researchers will compare video game-facilitated group activity to regular occupational therapy to see if the intervention is beneficial to patients with chronic schizophrenia.

Participants will:

* Attend to video game-facilitated group activity or regular occupational therapy three times a week for 12 weeks.
* Receive assessments upon and after the 12-week intervention, and another 12 weeks after the intervention ends.

Conditions

  • Schizophrenia Patients

Interventions

BEHAVIORAL

Video game-facilitated group activity

The intervention is a 12-week group activity program for each participant in the intervention group, and the program consists of three 50-minute video game facilitated group activity sessions per week. Participants in the intervention group will engage in those group activity session which will be mediated by the game of Super Mario Party on Nintendo Switch.

Sponsors & Collaborators

  • TsaoTun Psychiatric Center, Department of Health, Taiwan

    lead OTHER

Principal Investigators

  • Yung-Jen Yang · Tsao-Tun Psychiatric Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-03
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07148609 on ClinicalTrials.gov